11611 North Meridian Street
Suite 330
Carmel, IN 46032
United States
(812) 689-0791
https://neuraxis.com
Settore/i: Healthcare
Settore: Biotechnology
Impiegati a tempo pieno: 19
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Brian Carrico | President, CEO & Director | 839,4k | N/D | 1982 |
Mr. Timothy Robert Henrichs | Chief Financial Officer | 23,84k | N/D | 1973 |
Dr. Adrian Miranda | Senior VP of Science & Technology and Chief Medical Officer | 323,05k | N/D | 1970 |
Dr. Thomas Carrico | Chief Regulatory Officer and Compliance & Privacy Officer | 411,1k | N/D | 1957 |
Dr. Christopher Robin Brown D.D.S. | Founder, Director of Innovation & Director | N/D | N/D | 1954 |
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
L'ISS Governance QualityScore di NeurAxis, Inc. al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.